During the past decade, Bacs-kiskun Megyei Korhaz conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 24 clinical trials were completed, i.e. on average, 46.2% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 16 clinical trials were completed. i.e. 55.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bacs-kiskun Megyei Korhaz" #1 sponsor was "Pfizer" with 8 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bacs-kiskun Megyei Korhaz" #1 collaborator was "BioNTech SE" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Cephalon" with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Bacs-kiskun Megyei Korhaz" are "Psoriasis" (5 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (3 trials), "Cervical Cancer" (3 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Bacs-kiskun Megyei Korhaz" in a lesser frequency.

Most popular intervention types in "Bacs-kiskun Megyei Korhaz" are "Drug" (57 trials), "Device" (5 trials), "Biological" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Carboplatin" (5 trials), "Abemaciclib" (3 trials), "Cisplatin" (2 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bacs-kiskun Megyei Korhaz" are 58 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bacs-kiskun Megyei Korhaz". undefined are not yet recruiting, 17 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Bacs-kiskun Megyei Korhaz, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Bacs-kiskun Megyei Korhaz, 4 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Bacs-kiskun Megyei Korhaz has several departments that took part in Clinical trials: "Bacs-Kiskun Megyei Korhaz, SZTE AOK Oktato Korhaza, Onkoradiologiai Kozpont" - 14 trials